Evaluation of functional GABAB receptors in dental pulp

Journal of Endodontics

Volumn 27, Issue 10, 2001, Pages 620-623

  Wurm, Cathy ^a   Richardson, Jennelle Durnett ^a   Bowles, Walter ^a   Hargreaves, Kenneth M ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR C3; G PROTEIN-COUPLED RECEPTOR C3; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); OPIATE RECEPTOR; PHACLOFEN; RADIOPHARMACEUTICAL AGENT; SULFUR;

ANIMAL; ARTICLE; BIOTRANSFORMATION; CATTLE; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; METABOLISM; NONPARAMETRIC TEST; TOOTH PULP;

ANIMALS; BACLOFEN; BIOTRANSFORMATION; CATTLE; DENTAL PULP; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; RADIOPHARMACEUTICALS; RECEPTORS, GABA-B; RECEPTORS, OPIOID; STATISTICS, NONPARAMETRIC; SULFUR RADIOISOTOPES;

EID: 0035491715     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004770-200110000-00005     Document Type: Article

References (16)

1. Doroschak A, Bowles W, Hargreaves KM. Evaluation of the combination of flurbiprofen and tramadol for management of endodontic pain. J Endodon 1999;25:660-3.
2. Nusstein J, Reader A, Nist R, Beck M, Meyers W. Anesthetic efficacy of the supplemental intraosseous injection of 2% lidocaine with 1:100,000 epinephrine in irreversible pulpitis. J Endodon 1998;24:487-91.
3. Rogers M, Johnson B, Remikis N, BeGole E. Comparison of effect of intracanal use of ketorolac tromethamine and dexamethasone with oral ibuprofen on post treatment endodontic pain. J Endodon 1999;25:381-4.
4. Hargreaves KM, Hutter JW. Endodontic pharmacology. In: Cohen S, Bums R, eds. Pathways of the pulp. 8th ed. St. Louis: Mosby (in press).
5. Fujikawa S, Motomura H, Ito Y, Ogata N. GABA B mediated upregulation of the high voltage activated calcium channels in rat dorsal root ganglia. Pflugers Archiv Eur J Physiol 1997;434:84-90.
6. Page A, Blackshaw L. GABA(B) receptors inhibit mechanosensitivity of primary afferent endings. J Neurosci 1999;19:8597-602.
7. Poorkhalkali N, Juneblad K, Jonsson A, Lindberg M, Karlsson O, Wallbrandt P, Ekstrand J, Lehmann A. Immunocytochemica! distribution of the GABA(B) receptor splice variants GABA(B) R1a and R1b in the rat CNS and dorsal root ganglia. Anat Embryol 2000;201:1-13.
8. Dirig DM, Yaksh TL. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther 1995;275:219-27.
9. Aran S, Hammond DL. Antagonism of baclofen-induced antinociception by intrathecal administration of phaclofen or 2-hydroxy-saclofen, but not delta-aminovaleric acid in the rat. J Pharmacol Exp Ther 1991;257:360-8.
10. Todd W, Kafrawy A, Newton C, Brown C. Immunohistochemical study of gamma aminobutyric acid and bombesin/gastrin releasing peptide in human dental pulp. J Endodon 1997;23:152-7.
11. Rose J, Garwood T, Jaber B. Prolactin concentrations in the skin of mink during the winter fur growth cycle. J Exp Zool 1995;271:205-10.
12. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 1995;92:7242-6.
13. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 1995;47:848-54.
14. Pozo D, Segura J, Jiminez-Rubio A, Garcia-Perganeda A, Bettahi I, Guerrero J. Identification of G-protein coupled receptor subunits in normal human dental pulp. J Endodon 2000;26:16-9.
15. Watling K, Kebabian J, Neumeyer J. The RBI handbook of receptor classification and signal transduction. Natick, MA: Research Biochemicals International, 1995:56-61.
16. Selley D, Breivogel C, Childers S. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 1993;44:731-41.